메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Ja Min Byun (Department of Internal Medicine, Seoul National University College of Medicine, Seoul National Univ) Seung-Joo Yoo (Department of Internal Medicine, Seoul National University College of Medicine, Seoul National Univ) Hyeong-Joon Kim (Department of Hematology-Oncology Chonnam National University Hwasun Hospital Hwasun Korea) Jae-Sook Ahn (Department of Hematology-Oncology Chonnam National University Hwasun Hospital Hwasun Korea) Youngil Koh (Department of Internal Medicine, Seoul National University College of Medicine, Seoul National Univ) Jun Ho Jang (Division of Hematology and Oncology Department of Medicine Samsung Medical Center Sungkyunkwan Univ) Sung-Soo Yoon (Department of Internal Medicine, Seoul National University College of Medicine, Seoul National Univ)
저널정보
대한혈액학회 Blood Research Blood Research Vol.57 No.1
발행연도
2022.3
수록면
13 - 19 (7page)
DOI
10.5045/br.2021.2021152

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
The mutational and epigenetic landscape of acute myeloid leukemia (AML) has become increasingly well understood in recent years, informing on biological targets for precision medicine. Among the most notable findings was the recognition of mutational hot-spots in the isocitrate dehydrogenase (IDH) genes. In this review, we provide an overview on the IDH1/2 mutation landscape in Korean AML patients, and compare it with available public data. We also discuss the role of IDH1/2 mutations as biomarkers and drug targets. Taken together, occurrence of IDH1/2 mutations is becoming increasingly important in AML treatment, thus requiring thorough examination and follow-up throughout the clinical course of the disease.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0